Literature DB >> 11316979

Glycosaminoglycans: urinary excretion in children with myelomeningocele.

E Salvaggio1, D Antuzzi, P Ferrara, M Scanu, S Pulitanò, L Venuti, E Tarquini, T De Michele, R Ricci.   

Abstract

BACKGROUND: The main consequences of neurogenic bladder dysfunction are renal damage related to high intravesical pressure, vesicoureteral reflux (VUR) and urinary tract infections (UTIs). Neurologic impairment, UTIs and VUR are known to be linked with a potential for renal scarring. Of paramount importance as predisposing conditions for UTIs in neurogenic bladder are poor bladder drainage and detrusor-sphincter dyssynergy which cause further abnormalities on the internal bladder surface and, consequently, a bladder wall rich in glycosaminoglycans (GAGs).
MATERIALS AND METHODS: The aim of this study is to investigate the correlation between GAG excretion and bladder wall degeneration in 43 patients affected by spina bifida (SB) and 40 healthy age-matched control children.
RESULTS: The amounts of GAGs excreted vary greatly in SB patients aged from 0 to 5 years, and values are comparable to those observed in normal controls. They are significantly higher in children over 5 years of age.
CONCLUSION: The increased excretion of GAGs in older SB patients is an important parameter in the evaluation of the physiopathological condition of the bladder wall and hence may be considered a possible marker for monitoring the beginning of bladder damage. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316979     DOI: 10.1159/000056597

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  4 in total

1.  Urinary levels of glycosaminoglycans in patients with idiopathic detrusor overactivity.

Authors:  Salvatore Siracusano; Antonio Cucchi; Stefano Ciciliato; Nicolitza Lampropoulou; Franco Vittur
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-08-12

2.  Urinary glycosaminoglycan excretion in patients with primary nocturnal enuresis.

Authors:  Yasemin U Budak; Kağan Huysal; Atilla Guray
Journal:  Ital J Pediatr       Date:  2010-02-03       Impact factor: 2.638

3.  Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study.

Authors:  Shucheng Liu; Ying Yu; Yang Gao; Xiong Yang; Zili Pang
Journal:  Urolithiasis       Date:  2015-08-05       Impact factor: 3.436

4.  Clinical and genetic characteristics of concomitant Mucopolysaccharidosis type IVA and neurogenic bladder in children: two case reports and literature review.

Authors:  Zhuhui Ge; Jianhua Mao; Huijun Shen; Yu Xu; Haidong Fu; Weiwei Zhang; Dongyan Li
Journal:  BMC Pediatr       Date:  2021-01-06       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.